Devices & Diagnostics Letter
Dec. 12, 2011
| Vol.
38 No.
49
Law Expert Says High Court Likely to Favor Prometheus Test Patent
The U.S. Supreme Court appears unconvinced after oral arguments on Prometheus Laboratories’ thiopurine metabolites test patent, but one legal expert predicts the high court will uphold an appeals court decision in favor of Prometheus.
This article is viewable by subscribers only. To view this article, please select an option below.
|